MDOT a good choice for poor HAART adherence

Source: Inpharma, Volume 1, Number 1561, 2006-10-28 , pp. 4-4(1)

Publisher: Adis International

Purchase options

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$37.95 plus tax      Refund Policy

OR

 
More like this?
Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial

Keywords: Antiretrovirals, therapeutic use; Cost-utility; HIV-infections, treatment

Document Type: Short communication

Back to top

Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in
Need to register?
Sign up here
Text size: A | A | A | A